KOD
Price
$5.18
Change
-$0.16 (-3.00%)
Updated
Nov 12, 03:26 PM (EDT)
Earnings call today
RIGL
Price
$27.42
Change
+$2.47 (+9.90%)
Updated
Nov 12, 03:34 PM (EDT)
Ad is loading...

KOD vs RIGL

Header iconKOD vs RIGL Comparison
Open Charts KOD vs RIGLBanner chart's image
Kodiak Sciences
Price$5.18
Change-$0.16 (-3.00%)
Volume$120
CapitalizationN/A
Rigel Pharmaceuticals
Price$27.42
Change+$2.47 (+9.90%)
Volume$152
CapitalizationN/A
KOD vs RIGL Comparison Chart
Loading...
KOD
Daily Signalchanged days ago
Gain/Loss if shorted
Show more...
RIGL
Daily Signalchanged days ago
Gain/Loss if shorted
Show more...
View a ticker or compare two or three
VS
KOD vs. RIGL commentary
Nov 12, 2024

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is KOD is a Hold and RIGL is a StrongBuy.

COMPARISON
Comparison
Nov 12, 2024
Stock price -- (KOD: $5.34 vs. RIGL: $24.96)
Brand notoriety: KOD and RIGL are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: KOD: 232% vs. RIGL: 396%
Market capitalization -- KOD: $280.96M vs. RIGL: $439.17M
KOD [@Biotechnology] is valued at $280.96M. RIGL’s [@Biotechnology] market capitalization is $439.17M. The market cap for tickers in the [@Biotechnology] industry ranges from $476.71B to $0. The average market capitalization across the [@Biotechnology] industry is $2.81B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

KOD’s FA Score shows that 1 FA rating(s) are green whileRIGL’s FA Score has 0 green FA rating(s).

  • KOD’s FA Score: 1 green, 4 red.
  • RIGL’s FA Score: 0 green, 5 red.
According to our system of comparison, KOD is a better buy in the long-term than RIGL.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

KOD’s TA Score shows that 3 TA indicator(s) are bullish while RIGL’s TA Score has 5 bullish TA indicator(s).

  • KOD’s TA Score: 3 bullish, 4 bearish.
  • RIGL’s TA Score: 5 bullish, 5 bearish.
According to our system of comparison, RIGL is a better buy in the short-term than KOD.

Price Growth

KOD (@Biotechnology) experienced а +36.92% price change this week, while RIGL (@Biotechnology) price change was +77.40% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +2.07%. For the same industry, the average monthly price growth was +12.75%, and the average quarterly price growth was +8.86%.

Reported Earning Dates

KOD is expected to report earnings on Mar 27, 2025.

RIGL is expected to report earnings on Aug 06, 2024.

Industries' Descriptions

@Biotechnology (+2.07% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
RIGL($439M) has a higher market cap than KOD($281M). KOD (75.658) and RIGL (72.138) have similar YTD gains . RIGL has higher annual earnings (EBITDA): -4.93M vs. KOD (-170.71M). KOD has more cash in the bank: 219M vs. RIGL (49.1M). RIGL has less debt than KOD: RIGL (60.3M) vs KOD (75.8M). RIGL has higher revenues than KOD: RIGL (130M) vs KOD (0).
KODRIGLKOD / RIGL
Capitalization281M439M64%
EBITDA-170.71M-4.93M3,466%
Gain YTD75.65872.138105%
P/E RatioN/AN/A-
Revenue0130M-
Total Cash219M49.1M446%
Total Debt75.8M60.3M126%
FUNDAMENTALS RATINGS
KOD vs RIGL: Fundamental Ratings
KOD
RIGL
OUTLOOK RATING
1..100
2829
VALUATION
overvalued / fair valued / undervalued
1..100
21
Undervalued
84
Overvalued
PROFIT vs RISK RATING
1..100
10077
SMR RATING
1..100
97100
PRICE GROWTH RATING
1..100
3434
P/E GROWTH RATING
1..100
100100
SEASONALITY SCORE
1..100
8585

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

KOD's Valuation (21) in the Biotechnology industry is somewhat better than the same rating for RIGL (84). This means that KOD’s stock grew somewhat faster than RIGL’s over the last 12 months.

RIGL's Profit vs Risk Rating (77) in the Biotechnology industry is in the same range as KOD (100). This means that RIGL’s stock grew similarly to KOD’s over the last 12 months.

KOD's SMR Rating (97) in the Biotechnology industry is in the same range as RIGL (100). This means that KOD’s stock grew similarly to RIGL’s over the last 12 months.

KOD's Price Growth Rating (34) in the Biotechnology industry is in the same range as RIGL (34). This means that KOD’s stock grew similarly to RIGL’s over the last 12 months.

KOD's P/E Growth Rating (100) in the Biotechnology industry is in the same range as RIGL (100). This means that KOD’s stock grew similarly to RIGL’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
KODRIGL
RSI
ODDS (%)
Bearish Trend 2 days ago
86%
Bearish Trend 2 days ago
67%
Stochastic
ODDS (%)
Bearish Trend 2 days ago
80%
Bearish Trend 2 days ago
80%
Momentum
ODDS (%)
Bullish Trend 2 days ago
83%
Bullish Trend 2 days ago
81%
MACD
ODDS (%)
N/A
Bullish Trend 2 days ago
80%
TrendWeek
ODDS (%)
Bullish Trend 2 days ago
85%
Bullish Trend 2 days ago
82%
TrendMonth
ODDS (%)
Bullish Trend 2 days ago
88%
Bullish Trend 2 days ago
82%
Advances
ODDS (%)
Bullish Trend 2 days ago
84%
Bullish Trend 2 days ago
82%
Declines
ODDS (%)
Bearish Trend 20 days ago
89%
Bearish Trend 13 days ago
86%
BollingerBands
ODDS (%)
Bearish Trend 2 days ago
90%
Bearish Trend 2 days ago
83%
Aroon
ODDS (%)
Bullish Trend 2 days ago
88%
Bearish Trend 2 days ago
89%
View a ticker or compare two or three
Ad is loading...
KOD
Daily Signalchanged days ago
Gain/Loss if shorted
Show more...
RIGL
Daily Signalchanged days ago
Gain/Loss if shorted
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
VSCOX29.030.36
+1.26%
JPMorgan Small Cap Blend A
TVIRX85.510.81
+0.96%
Thornburg Small/Mid Cap Core R4
RYEUX114.16N/A
N/A
Rydex Europe 1.25x Strategy H
PRJQX49.68N/A
N/A
PGIM Jennison Global Opportunities R6
MECEX14.87-0.03
-0.20%
NYLI Epoch Capital Growth Class C

KOD and

Correlation & Price change

A.I.dvisor indicates that over the last year, KOD has been loosely correlated with CRSP. These tickers have moved in lockstep 43% of the time. This A.I.-generated data suggests there is some statistical probability that if KOD jumps, then CRSP could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To KOD
1D Price
Change %
KOD100%
+8.54%
CRSP - KOD
43%
Loosely correlated
+6.28%
ACLX - KOD
42%
Loosely correlated
+3.37%
ABCL - KOD
42%
Loosely correlated
+16.30%
RXRX - KOD
42%
Loosely correlated
+10.42%
NTLA - KOD
42%
Loosely correlated
+4.66%
More

RIGL and

Correlation & Price change

A.I.dvisor indicates that over the last year, RIGL has been loosely correlated with ALLO. These tickers have moved in lockstep 43% of the time. This A.I.-generated data suggests there is some statistical probability that if RIGL jumps, then ALLO could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To RIGL
1D Price
Change %
RIGL100%
+13.09%
ALLO - RIGL
43%
Loosely correlated
-0.32%
NTLA - RIGL
42%
Loosely correlated
+4.66%
KOD - RIGL
41%
Loosely correlated
+8.54%
CMPX - RIGL
41%
Loosely correlated
+5.56%
RCUS - RIGL
41%
Loosely correlated
-0.56%
More